Get the Stockscreener App
133.79
0.79%
1.05
After Hours:
133.74
-0.05
-0.04%
State Street Spdr S P Biotech Etf stock is traded at $133.79, with a volume of 7.82M.
It is up +0.79% in the last 24 hours and down -0.83% over the past month.
See More
Previous Close:
$132.74
Open:
$132.98
24h Volume:
7.82M
Relative Volume:
0.88
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.98%
1M Performance:
-0.83%
6M Performance:
+8.66%
1Y Performance:
+58.59%
1-Day Range:
$132.96
$135.54
1-Week Range:
$127.56
$135.54
52-Week Range:
$80.90
$139.19
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
133.79 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
366.36 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
741.75 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
745.14 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
296.38 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
721.34 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
Biotech stocks are losing momentum despite rising M&A activity - MSN
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Database
Is State Street SPDR NYSE Technology ETF (XNTK) a Strong ETF Right Now? - Yahoo Finance
Biotech Sector Faces Challenges Despite Surge in M&A Activity - GuruFocus
Biotech is losing momentum despite strong M&A (XBI:NYSEARCA) - Seeking Alpha
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? - AOL.com
3 Longevity ETFs to Buy and Hold (and Hold) - Yahoo Finance
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech - AOL.com
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - AOL.com
ETFs Investing in Viking Therapeutics, Inc. Stocks - TradingView
ETFs Investing in ImmunityBio Inc Stocks - TradingView
PJP vs XBI: Pharmaceutical vs Biotech ETF Comparison for InvestorsNews and Statistics - IndexBox
SPDR S&P Pharmaceuticals and First Trust NYSE Arca Biotech ETFs Offer Distinct Healthcare Paths - sekbernews.id
Invesco vs. SPDR Healthcare ETFs: Biotech and Pharma Fund ComparisonNews and Statistics - IndexBox
Better Growth ETF: QQQM vs. VGT - The Motley Fool
Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. - Barron's
Vanguard Index Product Becomes First ETF to Top $1 Trillion in Assets - US News Money
VOO: What to Know About the First Trillion-Dollar ETF - Barchart.com
Skip the SPY ETF: These Two Low-Cost S&P 500 ETFs Have 15%+ Upside, According to Analysts - TipRanks
HSBC Asset Management Predicts Dollar Weakness Ahead - GuruFocus
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
MGK Owns Today's Winners. SLYG Is Betting on Tomorrow's. - Yahoo Finance
Iran: 'Waiting For Godot' - Seeking Alpha
State Street's Health Care ETF Tops Invesco's on Yield and Returns - The Motley Fool
Australia's Economic Deficit Grows to AUD 27.1 Billion Amid Trad - GuruFocus
Mergers and Acquisitions Are Heating Up. These Are The Sectors Getting a Boost - Barron's
Healthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio? - NAI500
Turkey's Economy Grows 2.5% in Q1 Amid Inflation Pressures - GuruFocus
India's Inflation Outlook Amid Rising Fuel Prices and Geopolitical Tensions - GuruFocus
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost - AOL.com
7 Best Socially Responsible Funds | Investing - US News Money
Vanguard and SPDR Offer Diverse Strategies for Health Care Investors - HarianBasis.co
Worse Than 1999 - Seeking Alpha
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost - The Motley Fool
Best ETFs to Invest In, According to AI Analyst, 5/27/2026 - TipRanks
Apogee Stock Slides After Blackstone Financing Deal And Positive Drug DataApogee Therapeutics (NASDAQ - Benzinga
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
SENEB Q1 2026 Earnings: Strong EPS Performance Amidst Uncertain MarketReturn On Capital - thelegaladvocate.com
Hagerty Inc. (HGTY) Pulls Back 2.3%: Key Support Levels in FocusIchimoku TK Cross - thelegaladvocate.com
SA Asks: What are the most attractive biotech stocks right now? (XBI:NYSEARCA) - Seeking Alpha
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
If you hold this healthcare ETF, you’re losing big - MSN
Is State Street SPDR S&P Transportation ETF (XTN) a Strong ETF Right Now? - Yahoo Finance
Should You Rebalance Into an Aerospace and Defense ETF Before June? - Yahoo Finance
Fidelity MSCI Health Care ETF (FHLC) Performance Analysis - HarianBasis.co
If You Hold This Healthcare ETF, You’re Losing Big - AOL.com
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):